GMP: EMA Reflection Paper on Sourcing Biological Starting Materials

After the FDA has recently published a draft Guidance on Monitoring Crude Heparin for Quality, the European Medicines Agency EMA has now drafted a Reflection Paper on the use of starting materials and intermediates collected from different sources in the manufacturing of biological medicinal products.